Article Text
PDFEconomic analysis
Screening for postmenopausal osteoporosis with any modality is cost-effective including screening initiation at 55 years of age
Statistics from Altmetric.com
Footnotes
Competing interests None.
Request Permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information:
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions